|4Jan 2, 4:29 PM ET

Brockstedt Dirk G. 4

4 · RAPT Therapeutics, Inc. · Filed Jan 2, 2024

Insider Transaction Report

Form 4
Period: 2023-12-29
Brockstedt Dirk G.
CHIEF SCIENTIFIC OFFICER
Transactions
  • Exercise/Conversion

    Common Stock

    2023-12-29$6.18/sh+8,000$49,44027,070 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2023-12-29+8,0007,690 total
    Exercise: $6.18Exp: 2028-03-27Common Stock (8,000 underlying)
Footnotes (1)
  • [F1]Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Documents

1 file
  • 4
    primary_01.xmlPrimary

    PRIMARY DOCUMENT